July 22, 2020A new interactive video series and digital course1 aim to educate patients with attention deficit hyperactivity disorder (ADHD or ADD) and their caregivers about the safe use of prescription stimulant medications.
Adlon Therapeutics and the Prescription Drug Safety Network (PDSN) released these resources in an effort to address prescription drug misuse among adolescents and young adults.
Prescription stimulants, which are classified as Schedule II controlled substances by the Drug Enforcement Administration, have a high potential for abuse.The Prescription Drug Safety curriculum covers the safe use of opioids, stimulants, and anti-depressants and has been shared with more than 600,000 American students since 2017.
Read more on additudemag.com